Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

NRC Health Earnings Call: Key Takeaways

NRC Health returned to double-digit growth in Q3 2026, driven by a major customer implementation and strong performance in Market Insights and Governance Institute segments.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthRevenue grew 11% to $38M; TRCV grew 9% to $154M.
Mgmt ConfidenceHigh confidence in returning to growth and seeing clear multi-quarter progression.
Demand VisibilityPipeline deals increased; TRCV of $154M provides strong recurring revenue visibility.
Order BookTotal recurring contract value (TRCV) reached $154 million, up 9% year-over-year.
Margin TrendsAdjusted EBITDA margin 28%; 4% headwind from HUB conference timing shift.
Op. LeverageRevenue now absorbing delivery capacity investments; incremental dollars expected at additive margins.
Pricing PowerStrong retention; several longstanding customers moved to multi-year agreements.
Vol vs PriceGrowth driven by large implementation and broad-based strength across portfolio segments.
Segment GrowthMarket Insights strongest sales since pandemic; Governance Institute strongest in decade.
New ClientsLarge multi-solution agreement went live; several new Market Insights logos added.
Capex & DebtPaid $0.16 dividend; repurchased 790,000 shares; reduced capital expenditures.
CommentaryFocusing on moving from measuring experience to enabling frontline improvement actions.
New LaunchesPiloting AI-enabled capabilities for data access and actionable insights.

Growth

Revenue grew 11% to $38M; TRCV increased 9% to $154M year-over-year.

Outlook

Expect further sequential margin improvement in Q4 2026 and continued TRCV-to-revenue conversion.

Risks

Management used vague language regarding the specific revenue contribution timing for the 2027 rounding platform phase.

Source

The company's earnings call, NASDAQ: NRC, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Nrc Health: key numbers

Share price
$26.33Close, Nov 16
Market cap
$559M
Shares outstanding
21.22MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological ResearchSIC 8731

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Nrc Health

All →
2:58 PM ET 10-Q
Financial Results

Nrc Health Q3 2026 Results: Net Income $4.7M, Up 14.1% YoY

NRC Health reported revenue of $38.4 million for the third quarter of 2026, an 11% increase over the prior year, though nine-month operating income fell from $17.9 million to $11.2 million due to higher selling, general, and administrative expenses. The company maintained its quarterly dividend of $0.16 per share while significantly increasing treasury stock repurchases, contributing to a total shareholders' deficit of $9.1 million.

Key figure
Net income $4.7M · +14.1% YoY
4:03 PM ET 8-K
Financial Results

Nrc Health Financial Results

NRC Health reported third-quarter 2026 revenue of $38.4 million, an 11% increase year-over-year, driven by the successful launch of a large customer and multi-year renewals. The company also declared a quarterly cash dividend of $0.16 per share payable in January 2027.

Term
Q3 2026

“We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion. Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base. As our expanding contract base converts into revenue, the operating leverage inherent in our model will translate into greater profitability and free cash flow over time, reinforcing our confidence in NRC Health’s ability to create long-term shareholder value.”

Trent Green, CEO of NRC Health
10:29 AM ET 8-K
Leadership Change

Nrc Health Leadership Change

NRC Health has appointed its current CEO, Trent Green, to the additional role of interim principal financial officer effective October 14, 2026. No compensation changes were made in connection with this appointment, and Mr. Green has served as the company's CEO since June 2025.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.